Tesaglitazar as add-on therapy to atorvastatin further improves the lipid profile in subjects with dyslipidemia

被引：0
|
作者：
Tonstad, S.
Retterstol, K.
Ose, L.
Ohman, P.
Lindberg, M.
Svensson, M.
机构：
来源：
DIABETES | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A135 / A136
页数：2
相关论文
共 50 条
  • [1] The dual peroxisome proliferator-activated receptor α/γ agonist tesaglitazar further improves the lipid profile in dyslipidemic subjects treated with atorvastatin
    Tonstad, Serena
    Retterstol, Kjetil
    Ose, Leiv
    Oehman, K. Peter
    Lindberg, Magnus B.
    Svensson, Maria
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2007, 56 (09): : 1285 - 1292
  • [2] Atorvastatin as add-on therapy in asthmatic patients: effect on lung function and morbidity
    Zivkovic, M.
    Moskoljevic, J.
    Kamenov, S.
    ALLERGY, 2008, 63 : 610 - 610
  • [3] Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia
    Yamaoka-Tojo, Minako
    Tojo, Taiki
    Kosugi, Rie
    Hatakeyama, Yuko
    Yoshida, Yuki
    Machida, Yoji
    Aoyama, Naoyoshi
    Masuda, Takashi
    Izumi, Tohru
    LIPIDS IN HEALTH AND DISEASE, 2009, 8
  • [4] Pleiotropic Effects Of Add-On Atorvastatin Therapy During The Treatment Of COPD Patients
    Mroz, R. M.
    Tycinska, A.
    Minarowski, L.
    Bierla, J.
    Lisowski, P.
    Sobkowicz, B.
    Chyczewska, E.
    Musial, W. J.
    MacNee, W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [5] Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia
    Minako Yamaoka-Tojo
    Taiki Tojo
    Rie Kosugi
    Yuko Hatakeyama
    Yuki Yoshida
    Yoji Machida
    Naoyoshi Aoyama
    Takashi Masuda
    Tohru Izumi
    Lipids in Health and Disease, 8
  • [6] Effects of pitavastatin add-on therapy on chronic kidney disease with albuminuria and dyslipidemia
    Masato Ohsawa
    Kouichi Tamura
    Hiromichi Wakui
    Tomohiko Kanaoka
    Kengo Azushima
    Kazushi Uneda
    Sona Haku
    Ryu Kobayashi
    Kohji Ohki
    Kotaro Haruhara
    Sho Kinguchi
    Yoshiyuki Toya
    Satoshi Umemura
    Lipids in Health and Disease, 14
  • [7] Effects of pitavastatin add-on therapy on chronic kidney disease with albuminuria and dyslipidemia
    Ohsawa, Masato
    Tamura, Kouichi
    Wakui, Hiromichi
    Kanaoka, Tomohiko
    Azushima, Kengo
    Uneda, Kazushi
    Haku, Sona
    Kobayashi, Ryu
    Ohki, Kohji
    Haruhara, Kotaro
    Kinguchi, Sho
    Toya, Yoshiyuki
    Umemura, Satoshi
    LIPIDS IN HEALTH AND DISEASE, 2015, 14
  • [8] EFFECTS OF ATORVASTATIN-FENOFIBRATE COMBINATION COMPARED TO ATORVASTATIN MONOTHERAPY ON LIPID PROFILE IN PATIENTS WITH COMBINED DYSLIPIDEMIA
    Derosa, G.
    Salvadeo, S.
    Ferrari, I.
    Cicero, A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [9] The Effects of Atorvastatin Therapy on Rheological Characteristics of Erythrocyte Membrane, Serum Lipid Profile and Oxidative Status in Patients with Dyslipidemia
    Hüseyin Avni Uydu
    Sermet Yıldırmış
    Cihan Örem
    Mustafa Calapoglu
    Ahmet Alver
    Birgül Kural
    Asım Örem
    The Journal of Membrane Biology, 2012, 245 : 697 - 705
  • [10] The Effects of Atorvastatin Therapy on Rheological Characteristics of Erythrocyte Membrane, Serum Lipid Profile and Oxidative Status in Patients with Dyslipidemia
    Uydu, Huseyin Avni
    Yildirmis, Sermet
    Orem, Cihan
    Calapoglu, Mustafa
    Alver, Ahmet
    Kural, Birgul
    Orem, Asim
    JOURNAL OF MEMBRANE BIOLOGY, 2012, 245 (11): : 697 - 705
12345